SUVRETTA CAPITAL MANAGEMENT, LLC
"13F equity value" = market value of this filer's US-listed long equity positions only. It excludes cash, bonds, non-US and short positions, so it understates a fund's true assets under management — often by a lot.
13F holdings are disclosed ~45 days after quarter-end, and they never reveal when within the quarter a fund actually bought. So any 13F-based summary is structurally late and blurred — this applies to every fund, including this one.
We backtested copying it anyway. Buying this fund's new positions the day each filing went public, over 32 quarters, returned +2.8% per quarter — versus +2.7% per quarter from simply owning every 13F stock. It beat that baseline in only 59.4% of quarters (excess t = 0.30, not statistically significant). Its filings tell you what it bought — not what you should buy.
Quarterly compounding, invested quarters only · entry 47 days after quarter-end (when 13F data becomes public)
Top 20 holdings of 88 · 2026 Q1
| Ticker | Value | Weight | QoQ |
|---|---|---|---|
| ARQT | $290M | | ADD |
| MANE | $263M | | NEW |
| PVLA | $144M | | ADD |
| APLS | $142M | | TRIM |
| LEGN | $137M | | ADD |
| BNTC | $123M | | HOLD |
| CAPR | $116M | | ADD |
| IMTX | $110M | | HOLD |
| RCUS | $109M | | TRIM |
| EYPT | $107M | | ADD |
| AVBP | $102M | | ADD |
| TSM | $101M | | ADD |
| NVDA | $100M | | ADD |
| META | $97M | | HOLD |
| KALV | $96M | | HOLD |
| GE | $88M | | HOLD |
| BHVN | $87M | | HOLD |
| SYY | $83M | | ADD |
| MGM | $80M | | ADD |
| CMPX | $76M | | HOLD |
QoQ vs previous quarter's share count · NEW = new position · ADD/TRIM = ±2% shares · HOLD = unchanged.
New positions in 2026 Q1
Method & Limitations
Method: a "new position" = held this quarter, absent last quarter (options excluded; stocks with <50 prior holders excluded to filter spin-off artifacts). Entry 47 days after quarter-end — the first day the public could act on the filing. Benchmark = equal-weighted universe of all 13F-held stocks. Limitations: quarterly snapshots can't see intra-quarter trades; survivorship bias — funds that shut down are absent, which flatters the sample. Statistics, not advice.